Page 17 - Pharma

Syngene closes deal to buy Strand Life's bioinformatics platforms

The deal to boost Syngene's bioinformatics and data analytics capabilities

Indoco Remedies buys Micro Labs' manufacturing facility in Baddi

The acquired facility, which produces 4.3 billion tablets and 50 million capsules per annum, is close to Indoco's existing manufacturing plant in Baddi

Altem launches 3D printers for dental clinics

Printers will enable any lab or dental clinic to fabricate stone models from their desk tops for appliances, delivery and positioning trays, models for clear aligners, retainers and surgical guides

Essel Propack takes over German packaging JV

The company has raised the stake in Essel Deutschland GmbH from present 24.9% to 100% providing it a strong platform for growth especially in the non-oral care category in Europe

Novasep and Triclinic Labs to jointly develop solid-state chemistry services

Partnership will enable Novasep to offer early-stage solid-state chemistry services in North America

Dr Reddy's launches vitamin D analog paricalcitol injection in US

The approved product is the generic version of Abbvie Inc's Zemplar injection

Suresh Subramanian to head Biocon's branded formulations business in India

He has over 30 years of experience in the pharmaceuticals market, having worked in India and Thailand for MNCs such as GlaxoSmithKline, Novartis, AstraZeneca and Pfizer

Zydus partners with Japan's Takeda to develop vaccine for chikungunya

Early stage project will develop a vaccine for chikungunya, for which there is currently no vaccine or medicine to treat it

Glenmark inks pact with Lubrizol arm Particle Sciences to develop generic cancer drug

As per the deal, Glenmark will have global exclusive marketing rights of the product - a generic version of cancer drug Abraxane that had worldwide sales of $ 967 million in 2015

Themis Medicare joins hand with Nevakar to tap US pharma market

As per the deal, Themis will develop a selected number of injectable products that will be manufactured and commercialised by Nevakar in the US and select global markets

Dr Reddy's expands collaboration with US-based Amgen in India

As per the deal, the company will market and distribute Amgen's three medicines in India in the therapy areas of oncology and osteoporosis

Atos acquires Anthelio Healthcare for $ 275 million

Acquisition of Anthelio, an outsourcing services provider, brings more than 1,700 healthcare professionals to Atos, of which 1,300 are in the US and 400 in India

Horizon Pharma buys Raptor Pharmaceutical for $ 800 million

The deal will strengthen Irish firm's focus on rare diseases and expand its operations in Europe and other international markets

Sanofi and Google form JV to develop diabetes management platform

The JV, named Onduo, will leverage Verily Life Sciences' experience in miniaturised electronics, analytics, and consumer software development, and Sanofi's clinical expertise

Protein Sciences bags mega contract from US HHS for influenza vaccines

The company stands to receive up to $ 610 million through 2021 if US Biomedical Advanced Research and Development Authority (BARDA) exercises all options

Thermo Fisher opens clinical services facility in South Korea

Over the past few years, clinical trials have consistently grown in South Korea, making it a leading emerging nation for clinical trial research in Asia

Asahi Glass buys German biopharmaceutical CMO Biomeva

With this acquisition, AGC's life science business will be able to expand its geographic coverage and offer a wider range of capacities

Aralez acquires US and Canadian rights to Zontivity from Merck

Zontivity is the first and only approved therapy shown to inhibit the protease-activated receptor-1, the primary receptor for thrombin, which is considered to be the most potent activator of platelets

Glenmark receives US FDA approval for skin ointment lidocaine

The approved product is the generic version of AstraZeneca's Xylocaine ointment (5%), which recorded annual sales of approximately $ 373 million

Skin care specialist Kaya Ltd acquires 75% stake in two UAE firms

The company has acquired 75 percent stake in Minal Medical Centre, Dubai, and Minal Specialized Clinic Dermatology, Sharjah